Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
Clinical trial NCT05055908 · RECRUITING
Trial details
- NCT number
- NCT05055908
- Sponsor
- Hunan Province Tumor Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2025-07-01
- Enrollment
- 12000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.